Clinical updates of JAK inhibitors in cutaneous granulomatous diseases
Cutaneous granulomatous diseases, characterized by persistent granuloma formation, often exhibit chronic and relapsing courses that are challenging to manage with conventional therapies. The Janus kinase (JAK)–signal transducer and activator of transcr…